Andritsos, Leslie A <br/><br/>
Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization.  [electronic resource] 

 -  Leukemia research  10 2019 
 - 106215 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-5835 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2019.106215  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Benzylamines<br/>Costs and Cost Analysis<br/>Cyclams<br/>Female<br/>Health Care Costs<br/>Hematopoietic Stem Cell Mobilization--economics<br/>Hematopoietic Stem Cell Transplantation--economics<br/>Heterocyclic Compounds--administration & dosage<br/>Hospitalization--economics<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--diagnosis<br/>Retrospective Studies